Brief: SciVision Biotech gets third category of medical materials sales license from TFDA for its products used for obstetrics and gynecology and urology
Feb 15 (Reuters) - SciVision Biotech Inc 1786.TW :
* Says it got the third category of medical materials sales
license from TFDA for its two products used for obstetrics and
gynecology and urology
Source text in Chinese: https://goo.gl/m6hV83;
https://goo.gl/o73pGa
Further company coverage: 1786.TW
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com;)(+86 010
62674724;)(Reuters
Messaging:)(shuai.liu.reuters.com@reuters.net))
Recent news on Scivision Biotech
See all newsBrief: SciVision Biotech says 2017 dividend record date is June 23
Brief: SciVision Biotech scraps issuance plan of 1st overseas secured convertible corporate bonds
Brief: SciVision Biotech receives EU patent
Brief: SciVisison Biotech says no dividend for 2016
Brief: SciVision Biotech gets third category of medical materials sales license from TFDA for its products used for obstetrics and gynecology and urology